Eli Lilly

Eli Lilly Updates Spondyloarthritis Trial Data and Long-Term Rheumatoid Arthritis Studies
Eli Lilly Updates Spondyloarthritis Trial Data and Long-Term Rheumatoid Arthritis Studies
BioSpace
Eli Lilly
Taltz
asxSpA
Flag link:
Pfizer-Lilly non-opioid drug helps reduce osteoarthritis pain
Pfizer-Lilly non-opioid drug helps reduce osteoarthritis pain
Yahoo/Reuters
Pfizer
Eli Lilly
osteoarthritis
opioid alternatives
painkillers
Flag link:
Teva slumps after Express Scripts funds migraine rivals in US
Teva slumps after Express Scripts funds migraine rivals in US
Pharmaforum
PBMs
Teva Pharmaceutical
migraines
Ajovy
Express Scripts
Eli Lilly
Amgen
Flag link:
Minnesota takes aim at Sanofi, Novo, Lilly for insulin prices
Minnesota takes aim at Sanofi, Novo, Lilly for insulin prices
Biopharma Dive
Minnesota
insulin
diabetes
PBMs
Sanofi
Novo Nordisk
Eli Lilly
Flag link:
Express Scripts covers Amgen, Lilly migraine therapies, excludes Teva drug
Express Scripts covers Amgen, Lilly migraine therapies, excludes Teva drug
Yahoo/Reuters
Express Scripts
PBMs
migraines
Eli Lilly
Amgen
Teva Pharmaceutical
Emgality
Aimovig
Ajovy
Flag link:
Trump wants drug commercials to include prices. These five companies have the most at stake
Trump wants drug commercials to include prices. These five companies have the most at stake
Stat
Donald Trump
drug ads
drug pricing
Pfizer
AbbVie
Eli Lilly
Amgen
Allergan
Flag link:
New York biotech snaps up Eli Lilly neuro veteran as CSO
New York biotech snaps up Eli Lilly neuro veteran as CSO
Fierce Biotech
Redpin Therapeutics
Eli Lilly
JLabs
gene therapy
Flag link:
Lilly, Merck and Pfizer lead pharma's share price gains through 9 months: report
Lilly, Merck and Pfizer lead pharma's share price gains through 9 months: report
Fierce Pharma
drug pricing
Eli Lilly
Merck
Pfizer
Flag link:
New Analysis Suggests that Jardiance Could Add Years to Life Expectancy of Adults With Type 2 Diabetes and Cardiovascular Disease
New Analysis Suggests that Jardiance Could Add Years to Life Expectancy of Adults With Type 2 Diabetes and Cardiovascular Disease
CP Wire
Jardiance
Boehringer Ingelheim
Eli Lilly
diabetes
type 2 diabetes
Flag link:
New Analysis Suggests that Jardiance Could Add Years to Life Expectancy of Adults With Type 2 Diabetes and Cardiovascular Disease
Jardiance
Boehringer Ingelheim
Eli Lilly
Flag link:
4 Reasons to Be Wary of This Animal Health IPO
4 Reasons to Be Wary of This Animal Health IPO
Motley Fool
Elanco
IPOs
Eli Lilly
animal health
Flag link:
Lilly makes waves with next-generation diabetes drug, but GLP-1 rivals needn't panic: analysts
Lilly makes waves with next-generation diabetes drug, but GLP-1 rivals needn't panic: analysts
Fierce Pharma
diabetes
Eli Lilly
GIP/GLP-1 RA
Flag link:
Lilly’s breast cancer drug Verzenio approved in EU
Lilly’s breast cancer drug Verzenio approved in EU
Pharmaforum
Eli Lilly
Verzenio
Euorpe
breast cancer
Flag link:
Lilly, Boehringer hit heart safety mark with Januvia rival Tradjenta. Is that enough?
Lilly, Boehringer hit heart safety mark with Januvia rival Tradjenta. Is that enough?
Fierce Pharma
Boehringer Ingelheim
Eli Lilly
Tradjenta
diabetes
Flag link:
Eli Lilly ushers up-and-coming GIP/GLP-1 drug into PhIII as Novo Nordisk rival wows with impressive results
Eli Lilly ushers up-and-coming GIP/GLP-1 drug into PhIII as Novo Nordisk rival wows with impressive results
Endpoints
Eli Lilly
diabetes
Novo Nordisk
Ozempic
LY3298176
Trulicity
Flag link:
Eli Lilly's diabetes treatment meets main goal in two late-stage studies
Eli Lilly's diabetes treatment meets main goal in two late-stage studies
Reuters
Eli Lilly
Ultra Rapid Lispro
Humalog
diabetes
type 1 diabetes
type 2 diabetes
Flag link:
Three new drugs will compete fiercely to revolutionize migraine treatment — with identical $6,900 price tags
Three new drugs will compete fiercely to revolutionize migraine treatment — with identical $6,900 price tags
Marketwatch
migraines
Eli Lilly
Emgality
Teva Pharmaceutical
Ajovy
Amgen
Novartis
Aimovig
Flag link:
Teva launches first U.S. generic Cialis as Eli Lilly braces for loss of its ED blockbuster
Teva launches first U.S. generic Cialis as Eli Lilly braces for loss of its ED blockbuster
Fierce Pharma
Eli Lilly
Cialis
generics
Teva Pharmaceutical
erectile dysfunction
Flag link:
Lilly’s Emgality nabs third-to-market migraine nod, but aims to be 'treatment of choice' in CGRP
Lilly’s Emgality nabs third-to-market migraine nod, but aims to be 'treatment of choice' in CGRP
Fierce Pharma
Eli Lilly
Emgality
migraines
Flag link:
Lilly Licenses Chugai Pharma's Oral Diabetes Drug for $50 Million Upfront
Lilly Licenses Chugai Pharma's Oral Diabetes Drug for $50 Million Upfront
BioSpace
Eli Lilly
Chugai
OWL833
type 2 diabetes
Flag link:

Pages